التفاصيل البيبلوغرافية
| العنوان: |
Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus. |
| المؤلفون: |
Lorenzo, Petra I1, Cobo-Vuilleumier, Nadia1, Gauthier, Benoit R1 benoit.gauthier@cabimer.es |
| المصدر: |
Current Opinion in Pharmacology. Dec2018, Vol. 43, p1-10. 10p. |
| مصطلحات موضوعية: |
*DIABETES, *TREATMENT of diabetes, *INSULIN, *PEPTIDES, *MATERIAL plasticity |
| مستخلص: |
Highlights • Diabetes mellitus is a worldwide health problem with major economical ramifications. • There is an urgent need to identify novel targets for diabetes therapeutics. • PAX4, a β-cell enriched factor, displays both immune and regenerative properties. • PAX4 and downstream targets offer new prospects in diabetes treatment. The high prevalence of diabetes mellitus (DM) in our society, together with the fact that current treatments are only palliative and do not prevent the development of life threatening side effects, highlights the urgent need for novel therapies targeting the root cause of the disease. Independent of the etiology of DM, the definitive therapeutic approach will imply the restitution of an adequate functional β-cell mass capable of compensating for the insulin demand of the organism. The recent demonstration of heterogeneity within the islets as well as their innate plasticity has encouraged the development of studies aiming at potentiation of the regenerative capacity of islets. In this regard, factors implicated in pancreas ontogeny as well as in the adaptation processes that take place in the islets under situations of increased insulin demand have gained much interest. One of these factors is the transcription factor PAX4, required for β-cell formation during embryonic development and implicated in adult β-cell adaptation under stress situations. Here we review the therapeutic potential of PAX4 as well as its downstream targets for the development of novel treatments for DM. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
